Episode Details

US deaths more than 1918 pandemic Link to Wefwafwa’s channel https://www.youtube.com/channel/UCzsLklGgOttU3Se-WGLp7ow Link to todays featured video https://www.youtube.com/watch?v=XCKFBJRJcFA To donate to Wefwafwa’s work patreon:https://www.patreon.com/awmedicalvideos https://www.cdc.gov/flu/pandemic-resources/1918-pandemic-h1n1.html H1N1 virus with genes of avian origin United States, first identified in military in spring 1918 One-third of the world’s population became infected Global deaths, at least 50 million US deaths, 675,000 (CDC, 2021, 666,440) (JH, 2021, 681,199) https://coronavirus.jhu.edu/map.html (population, x 3 today) Pandemic subsides, but (H1N1) continues to circulate seasonally for 38 years https://www.cdc.gov/flu/pandemic-resources/1918-commemoration/milestone-infographic.htm Mortality in 1918 / 1919 High in people younger than 5 years old 20-40 years old, and 65 years and older No vaccine, no antibiotics UK in 1918 https://www.historic-uk.com/HistoryUK/HistoryofBritain/The-Spanish-Flu-pandemic-of-1918/ Deaths, 228,000 (2021, 135,621 to 158,664) Global infection fatality rate, 10% to 20% Mr Biden Extra 500 million Pfizer doses for poorer countries The Food and Drug Administration https://www.washingtonpost.com/health/2021/09/22/pfizer-booster-shot-fda-authorizes/ Authorized a Pfizer booster, 65 and older People 18 through 64, at high risk of severe illness frequent institutional or occupational exposure Six months Issuing emergency clearance FDA commissioner Janet Woodcock health care workers, teachers and day care staff, grocery workers, homeless shelters or prisons Centers for Disease Control and Prevention still must make precise recommendations Key goal of boosters, prevention of serious disease, not prevention of mild infection ? Pfizer booster for people who have been vaccinated with the Moderna or Johnson & Johnson Fewer side effects after third dose of mRNA vaccines compared with the second dose https://www.cdc.gov/vaccines/acip/meetings/downloads/slides-2021-09-22/07-COVID-Talbot-508.pdf COVID-19 Vaccine Safety Technical (VaST) Work Group Assessment of 3rd dose safety data H. Keipp Talbot, MD MPH (VaST Chair) Robert H. Hopkins, Jr., MD (NVAC Chair) Israel 3rd doses ,~2.8 M ≥12 years Most to persons ≥60 years Rates of reported systemic, local, neurologic, allergic, and other reactions were substantially lower after dose 3 than after dose 1 or 2 1,328 non serious 19 serious adverse events, (7 possibly associated with vaccination) https://www.who-umc.org/vigibase/vigibase/ http://www.vigiaccess.org Correction https://www.hindustantimes.com/cities/lucknow-news/yogi-adityanath-launches-covid-19-medical-kits-for-covid-19-symptomatic-children-101623747649057.html State government, 50 lakh medical kits through village surveillance committees

Learn more about your ad choices. Visit megaphone.fm/adchoices